Insulin therapy for type 2 diabetes: premixed or basal-prandial?

Abstract

It is logical to begin type 2 insulin therapy with an injection of an intermediate-acting or a long-acting insulin at bedtime, but one should treat to target, i.e. aim at fasting glycaemias lower than 1.20 g/l to obtain an HbA(1c) close to 7%. Nevertheless, basal insulin therapy does not prevent progression to insulin-secretory deficiency. If necessary… (More)

Topics

Cite this paper

@article{Halbron2007InsulinTF, title={Insulin therapy for type 2 diabetes: premixed or basal-prandial?}, author={Marine Halbron and Sophie Jacqueminet and Claude Sachon and Francisco Bosquet and Agn{\`e}s Hartemann-Heurtier and Antonio Grimaldi}, journal={Diabetes & metabolism}, year={2007}, volume={33 4}, pages={316-20} }